サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1697157

IVD試薬の世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）

IVD Reagents Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

出版日
ページ情報
英文 182 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
IVD試薬の世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）
出版日: 2025年04月01日
発行: Persistence Market Research
ページ情報: 英文 182 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のIVD試薬の市場規模は、2025年に774億米ドルになるとみられ、2025年～2032年の予測期間に6.4%のCAGRで拡大し、2032年には1,195億米ドルに達すると予測されています。

体外診断用（IVD）試薬は、診断検査に使用される重要なコンポーネントであり、様々な疾患の検出、モニタリング、治療を促進します。これらの試薬は、臨床検査室、病院、研究機関において、感染症検査から腫瘍学、遺伝子検査に至るまで幅広く使用されています。個別化医療が重視されるようになり、慢性疾患の有病率が上昇し、ポイントオブケア検査の需要が高まっていることが、市場を牽引する主な要因となっています。分子診断やイムノアッセイなどの診断技術の進歩が、体外診断用医薬品の需要をさらに押し上げています。

世界の体外診断用（IVD）試薬市場は、感染症、がんや糖尿病などの慢性疾患、疾病の早期発見の必要性など、いくつかの要因によって牽引されています。次世代シーケンシング（NGS）やポリメラーゼ連鎖反応（PCR）などの高度な診断技術の採用が、高品質な試薬の需要を加速しています。さらに、特に新興国におけるヘルスケアインフラの拡充は、診断サービスへのアクセス拡大を促進しています。疾病の早期診断を促進する政府の取り組みや医療費の増加も市場成長に寄与しています。

有望な成長が見込まれますが、体外診断用医薬品市場は、厳しい規制要件や高度な診断検査に伴う高コストといった課題に直面しています。新規試薬の規制承認の複雑さは市場参入を遅らせ、革新的ソリューションの開発に影響を与える可能性があります。さらに、検査結果の再現性や正確性に関する懸念が市場導入の妨げになる可能性もあります。特に資源が限られた環境では、特殊な試薬の高額なコストが普及の障壁となり、地域によっては市場拡大が制限されます。

体外診断用試薬市場は、診断技術の継続的な進歩とヘルスケア研究への投資の増加により、大きな成長機会をもたらしています。デジタル診断やAI主導型診断の台頭は検査の効率と精度を高め、市場参入者に新たな道を開くと期待されます。また、在宅検査キットや自己検査キットの動向の高まりも新たな収益源を開拓しています。さらに、新興国市場に合わせた費用対効果の高いソリューション開発のための試薬メーカーとヘルスケアプロバイダーとの提携は、有利な機会を提供します。精密医療におけるコンパニオン診断の応用拡大も成長の鍵となる分野です。

当レポートでは、世界のIVD試薬市場について調査し、試薬タイプ別、技術別、用途別、最終用途産業別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の範囲と定義
  • 市場力学
  • マクロ経済要因
  • COVID-19の影響分析
  • 予測要因- 関連性と影響

第3章 付加価値の洞察

第4章 世界のIVD試薬市場の見通し

  • 主なハイライト
  • 市場規模の分析と予測
    • 過去の市場規模分析、2019年～2024年
    • 現在の市場規模分析と予測、2025年～2032年
  • 世界のIVD試薬市場の見通し：試薬タイプ別
    • イントロダクション/主な調査結果
    • 過去の市場規模分析、試薬タイプ別、2019年～2024年
    • 現在の市場規模分析と予測、試薬タイプ別、2025年～2032年
    • 市場の魅力分析：試薬タイプ別
  • 世界のIVD試薬市場の見通し：技術別
    • イントロダクション/主な調査結果
    • 過去の市場規模分析、技術別、2019年～2024年
    • 現在の市場規模分析と予測、技術別、2025年～2032年
    • 市場の魅力分析：技術別
  • 世界のIVD試薬市場の見通し：用途別
    • イントロダクション/主な調査結果
    • 過去の市場規模分析、用途別、2019年～2024年
    • 現在の市場規模分析と予測、用途別、2025年～2032年
    • 市場の魅力分析：用途別
  • 世界のIVD試薬市場の見通し：最終用途産業別
    • イントロダクション/主な調査結果
    • 過去の市場規模分析、最終用途産業別、2019年～2024年
    • 現在の市場規模分析と予測、最終用途産業別、2025年～2032年
    • 市場の魅力分析：最終用途産業別

第5章 世界のIVD試薬市場の見通し：地域別

  • 主なハイライト
  • 過去の市場規模分析、地域業別、2019年～2024年
  • 現在の市場規模分析と予測、地域別、2025年～2032年
    • 北米
    • 欧州
    • 東アジア
    • 南アジアとオセアニア
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析：地域別

第6章 北米のIVD試薬市場の見通し

第7章 欧州のIVD試薬市場の見通し

第8章 東アジアのIVD試薬市場の見通し

第9章 南アジアおよびオセアニアのIVD試薬市場の見通し

第10章 ラテンアメリカのIVD試薬市場の見通し

第11章 中東・アフリカのIVD試薬市場の見通し

第12章 競合情勢

  • 市場シェア分析、2025年
  • 市場構造
  • 企業プロファイル（詳細- 概要、財務、戦略、最近の動向）
    • Abbott
    • Michelin
    • Agilent Technologies
    • Becton Dickinson
    • BioMerieux
    • Bio-Rad
    • Danaher
    • DiaSorin
    • Roche
    • Seegene
    • Sysmex
    • Thermo Fisher Scientific
    • Siemens Helthineers
    • Transasia Bio-Medicals Ltd.
    • Beacon Diagnostics Pvt. Ltd.
    • その他

第13章 付録

目次
Product Code: PMRREP35181

Persistence Market Research has recently released a comprehensive report on the worldwide market for IVD Reagents. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global IVD Reagents market from 2025 to 2032.

Key Insights:

  • IVD Reagents Market Size (2025E): US$ 77.4 Bn
  • Market Value Forecast (2032F): US$ 119.5 Bn
  • Projected Growth (CAGR 2025 to 2032): 6.4%

IVD Reagents Market - Report Scope:

IVD (In Vitro Diagnostics) reagents are essential components used in diagnostic testing, facilitating the detection, monitoring, and treatment of various diseases. These reagents are widely used in clinical laboratories, hospitals, and research institutions for applications ranging from infectious disease testing to oncology and genetic testing. The growing emphasis on personalized medicine, increased prevalence of chronic diseases, and rising demand for point-of-care testing are key factors driving the market. Technological advancements in diagnostic techniques, such as molecular diagnostics and immunoassays, are further fueling the demand for IVD reagents.

Market Growth Drivers:

The global IVD reagents market is driven by several factors, including the rising burden of infectious diseases, chronic conditions such as cancer and diabetes, and the need for early disease detection. The adoption of advanced diagnostic technologies, such as next-generation sequencing (NGS) and polymerase chain reaction (PCR), is accelerating the demand for high-quality reagents. Additionally, the expansion of healthcare infrastructure, particularly in emerging economies, is facilitating greater access to diagnostic services. Government initiatives promoting early disease diagnosis and increased healthcare expenditure are also contributing to market growth.

Market Restraints:

Despite promising growth prospects, the IVD reagents market faces challenges such as stringent regulatory requirements and high costs associated with advanced diagnostic testing. The complexity of regulatory approvals for new reagents can delay market entry, impacting the development of innovative solutions. Additionally, concerns regarding the reproducibility and accuracy of test results may hinder market adoption. The high costs of specialized reagents, particularly in resource-limited settings, pose a barrier to widespread use, limiting market expansion in some regions.

Market Opportunities:

The IVD reagents market presents significant growth opportunities driven by ongoing advancements in diagnostic technologies and increasing investment in healthcare research. The rise of digital and AI-driven diagnostics is expected to enhance the efficiency and accuracy of testing, creating new avenues for market players. The growing trend of at-home and self-testing kits is also opening new revenue streams. Additionally, partnerships between reagent manufacturers and healthcare providers for the development of cost-effective solutions tailored to emerging markets offer lucrative opportunities. The increasing application of companion diagnostics in precision medicine is another key area of growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the IVD reagents market globally?
  • How do advancements in molecular diagnostics impact the demand for IVD reagents?
  • Which diagnostic segments are experiencing the highest growth within the market?
  • Who are the key players in the IVD reagents market, and what strategies are they employing to maintain competitiveness?
  • What are the emerging trends and future growth prospects in the global IVD reagents market?

Competitive Intelligence and Business Strategy:

Leading players in the global IVD reagents market, including Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Danaher Corporation, and Bio-Rad Laboratories, are focusing on research and development, strategic partnerships, and product innovation to strengthen their market position. Companies are investing in automation and digital healthcare solutions to enhance diagnostic capabilities. Collaborations with biotech firms and research institutions for the development of novel reagents are also a key strategy. The expansion of product portfolios through mergers and acquisitions is further shaping the competitive landscape of the market.

Key Companies Profiled:

  • Abbott
  • Agilent Technologies
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Danaher
  • DiaSorin
  • Roche
  • Seegene
  • Sysmex
  • Thermo Fisher Scientific
  • Siemens Healthineers
  • Transasia Bio-Medicals Ltd.
  • Beacon Diagnostics Pvt. Ltd.

IVD Reagents Market Segmentation

By Type of Reagent

  • Antibodies
  • Antigens
  • Oligonucleotides
  • Enzymes
  • Nucleic Acid Probes

By Technology

  • Immunoassay
  • Molecular Diagnostics
  • Clinical Chemistry
  • Hematology
  • Microbiology

By Application

  • Infectious Diseases
  • Cancer/Oncology
  • Cardiology
  • Autoimmune Diseases
  • Genetic Testing
  • Neurology

By End-Use Industry

  • Hospitals
  • Clinical Laboratories
  • Point-of-Care Testing Facilities
  • Home Care Settings

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • The Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global IVD Reagents Market Snapshot, 2025-2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Regulatory Landscape
  • 3.2. Application Epidemiology
  • 3.3. Pipeline Analysis
  • 3.4. Product Adoption Analysis
  • 3.5. Value Chain Analysis
  • 3.6. Key Promotional Strategies by Manufacturers
  • 3.7. PESTLE Analysis
  • 3.8. Porter's Five Force Analysis

4. Global IVD Reagents Market Outlook:

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 4.3. Global IVD Reagents Market Outlook: Type of Reagent
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Type of Reagent, 2019-2024
    • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
      • 4.3.3.1. Antibodies
      • 4.3.3.2. Antigens
      • 4.3.3.3. Oligonucleotides
      • 4.3.3.4. Enzymes
      • 4.3.3.5. Nucleic Acid Probes
      • 4.3.3.6. Others
    • 4.3.4. Market Attractiveness Analysis: Type of Reagent
  • 4.4. Global IVD Reagents Market Outlook: Technology
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Bn) Analysis, By Technology, 2019-2024
    • 4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
      • 4.4.3.1. Immunoassay
      • 4.4.3.2. Molecular Diagnostics
      • 4.4.3.3. Clinical Chemistry
      • 4.4.3.4. Hematology
      • 4.4.3.5. Microbiology
      • 4.4.3.6. Others
    • 4.4.4. Market Attractiveness Analysis: Technology
  • 4.5. Global IVD Reagents Market Outlook: Application
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
    • 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
      • 4.5.3.1. Infectious Diseases
      • 4.5.3.2. Cancer/Oncology
      • 4.5.3.3. Cardiology
      • 4.5.3.4. Autoimmune Diseases
      • 4.5.3.5. Genetic Testing
      • 4.5.3.6. Neurology
      • 4.5.3.7. Others
    • 4.5.4. Market Attractiveness Analysis: Application
  • 4.6. Global IVD Reagents Market Outlook: End-Use Industry
    • 4.6.1. Introduction / Key Findings
    • 4.6.2. Historical Market Size (US$ Bn) Analysis, By End-Use Industry, 2019-2024
    • 4.6.3. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
      • 4.6.3.1. Hospitals
      • 4.6.3.2. Point-Of-Care Testing Facilities
      • 4.6.3.3. Home Care Settings
      • 4.6.3.4. Others
    • 4.6.4. Market Attractiveness Analysis: End-Use Industry

5. Global IVD Reagents Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
  • 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America IVD Reagents Market Outlook:

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Type of Reagent
    • 6.2.3. By Technology
    • 6.2.4. By Application
    • 6.2.5. By Application
    • 6.2.6. By End-Use Industry
  • 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
    • 6.4.1. Antibodies
    • 6.4.2. Antigens
    • 6.4.3. Oligonucleotides
    • 6.4.4. Enzymes
    • 6.4.5. Nucleic Acid Probes
    • 6.4.6. Others
  • 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
    • 6.5.1. Immunoassay
    • 6.5.2. Molecular Diagnostics
    • 6.5.3. Clinical Chemistry
    • 6.5.4. Hematology
    • 6.5.5. Microbiology
    • 6.5.6. Others
  • 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 6.6.1. Infectious Diseases
    • 6.6.2. Cancer/Oncology
    • 6.6.3. Cardiology
    • 6.6.4. Autoimmune Diseases
    • 6.6.5. Genetic Testing
    • 6.6.6. Neurology
    • 6.6.7. Others
  • 6.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
    • 6.7.1. Hospitals
    • 6.7.2. Point-Of-Care Testing Facilities
    • 6.7.3. Home Care Settings
    • 6.7.4. Others
  • 6.8. Market Attractiveness Analysis

7. Europe IVD Reagents Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Type of Reagent
    • 7.2.3. By Technology
    • 7.2.4. By Application
    • 7.2.5. By Application
    • 7.2.6. By End-Use Industry
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
    • 7.4.1. Antibodies
    • 7.4.2. Antigens
    • 7.4.3. Oligonucleotides
    • 7.4.4. Enzymes
    • 7.4.5. Nucleic Acid Probes
    • 7.4.6. Others
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
    • 7.5.1. Immunoassay
    • 7.5.2. Molecular Diagnostics
    • 7.5.3. Clinical Chemistry
    • 7.5.4. Hematology
    • 7.5.5. Microbiology
    • 7.5.6. Others
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 7.6.1. Infectious Diseases
    • 7.6.2. Cancer/Oncology
    • 7.6.3. Cardiology
    • 7.6.4. Autoimmune Diseases
    • 7.6.5. Genetic Testing
    • 7.6.6. Neurology
    • 7.6.7. Others
  • 7.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
    • 7.7.1. Hospitals
    • 7.7.2. Point-Of-Care Testing Facilities
    • 7.7.3. Home Care Settings
    • 7.7.4. Others
  • 7.8. Market Attractiveness Analysis

8. East Asia IVD Reagents Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Type of Reagent
    • 8.2.3. By Technology
    • 8.2.4. By Application
    • 8.2.5. By Application
    • 8.2.6. By End-Use Industry
  • 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
    • 8.4.1. Antibodies
    • 8.4.2. Antigens
    • 8.4.3. Oligonucleotides
    • 8.4.4. Enzymes
    • 8.4.5. Nucleic Acid Probes
    • 8.4.6. Others
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
    • 8.5.1. Immunoassay
    • 8.5.2. Molecular Diagnostics
    • 8.5.3. Clinical Chemistry
    • 8.5.4. Hematology
    • 8.5.5. Microbiology
    • 8.5.6. Others
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 8.6.1. Infectious Diseases
    • 8.6.2. Cancer/Oncology
    • 8.6.3. Cardiology
    • 8.6.4. Autoimmune Diseases
    • 8.6.5. Genetic Testing
    • 8.6.6. Neurology
    • 8.6.7. Others
  • 8.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
    • 8.7.1. Hospitals
    • 8.7.2. Point-Of-Care Testing Facilities
    • 8.7.3. Home Care Settings
    • 8.7.4. Others
  • 8.8. Market Attractiveness Analysis

9. South Asia & Oceania IVD Reagents Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Type of Reagent
    • 9.2.3. By Technology
    • 9.2.4. By Application
    • 9.2.5. By Application
    • 9.2.6. By End-Use Industry
  • 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
    • 9.4.1. Antibodies
    • 9.4.2. Antigens
    • 9.4.3. Oligonucleotides
    • 9.4.4. Enzymes
    • 9.4.5. Nucleic Acid Probes
    • 9.4.6. Others
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
    • 9.5.1. Immunoassay
    • 9.5.2. Molecular Diagnostics
    • 9.5.3. Clinical Chemistry
    • 9.5.4. Hematology
    • 9.5.5. Microbiology
    • 9.5.6. Others
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 9.6.1. Infectious Diseases
    • 9.6.2. Cancer/Oncology
    • 9.6.3. Cardiology
    • 9.6.4. Autoimmune Diseases
    • 9.6.5. Genetic Testing
    • 9.6.6. Neurology
    • 9.6.7. Others
  • 9.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
    • 9.7.1. Hospitals
    • 9.7.2. Point-Of-Care Testing Facilities
    • 9.7.3. Home Care Settings
    • 9.7.4. Others
  • 9.8. Market Attractiveness Analysis

10. Latin America IVD Reagents Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Type of Reagent
    • 10.2.3. By Technology
    • 10.2.4. By Application
    • 10.2.5. By Application
    • 10.2.6. By End-Use Industry
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
    • 10.4.1. Antibodies
    • 10.4.2. Antigens
    • 10.4.3. Oligonucleotides
    • 10.4.4. Enzymes
    • 10.4.5. Nucleic Acid Probes
    • 10.4.6. Others
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
    • 10.5.1. Immunoassay
    • 10.5.2. Molecular Diagnostics
    • 10.5.3. Clinical Chemistry
    • 10.5.4. Hematology
    • 10.5.5. Microbiology
    • 10.5.6. Others
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 10.6.1. Infectious Diseases
    • 10.6.2. Cancer/Oncology
    • 10.6.3. Cardiology
    • 10.6.4. Autoimmune Diseases
    • 10.6.5. Genetic Testing
    • 10.6.6. Neurology
    • 10.6.7. Others
  • 10.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
    • 10.7.1. Hospitals
    • 10.7.2. Point-Of-Care Testing Facilities
    • 10.7.3. Home Care Settings
    • 10.7.4. Others
  • 10.8. Market Attractiveness Analysis

11. Middle East & Africa IVD Reagents Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Type of Reagent
    • 11.2.3. By Technology
    • 11.2.4. By Application
    • 11.2.5. By Application
    • 11.2.6. By End-Use Industry
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
    • 11.4.1. Antibodies
    • 11.4.2. Antigens
    • 11.4.3. Oligonucleotides
    • 11.4.4. Enzymes
    • 11.4.5. Nucleic Acid Probes
    • 11.4.6. Others
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
    • 11.5.1. Immunoassay
    • 11.5.2. Molecular Diagnostics
    • 11.5.3. Clinical Chemistry
    • 11.5.4. Hematology
    • 11.5.5. Microbiology
    • 11.5.6. Others
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 11.6.1. Infectious Diseases
    • 11.6.2. Cancer/Oncology
    • 11.6.3. Cardiology
    • 11.6.4. Autoimmune Diseases
    • 11.6.5. Genetic Testing
    • 11.6.6. Neurology
    • 11.6.7. Others
  • 11.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
    • 11.7.1. Hospitals
    • 11.7.2. Point-Of-Care Testing Facilities
    • 11.7.3. Home Care Settings
    • 11.7.4. Others
  • 11.8. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Abbott
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Michelin
    • 12.3.3. Agilent Technologies
    • 12.3.4. Becton Dickinson
    • 12.3.5. BioMerieux
    • 12.3.6. Bio-Rad
    • 12.3.7. Danaher
    • 12.3.8. DiaSorin
    • 12.3.9. Roche
    • 12.3.10. Seegene
    • 12.3.11. Sysmex
    • 12.3.12. Thermo Fisher Scientific
    • 12.3.13. Siemens Helthineers
    • 12.3.14. Transasia Bio-Medicals Ltd.
    • 12.3.15. Beacon Diagnostics Pvt. Ltd.
    • 12.3.16. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations